IRadimed Corporation provided revenue guidance for the third quarter ended September 30, 2022. Third-quarter revenue is expected to be approximately $13.4 million, up 23% from the prior year and above the Company's third-quarter guidance of $13.1 million to $13.3 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.14 USD | +1.79% | -2.20% | -9.12% |
05-02 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.12% | 537M | |
+75.56% | 12.55B | |
-23.35% | 7.51B | |
+8.51% | 6.74B | |
+14.95% | 5.48B | |
-14.65% | 4.93B | |
+30.59% | 4.71B | |
-24.40% | 3.83B | |
-22.61% | 2.9B | |
+49.50% | 2.49B |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- IRadimed Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2022